These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 33955288)

  • 1. Short-chain fatty acids-producing probiotics: A novel source of psychobiotics.
    Cheng Y; Liu J; Ling Z
    Crit Rev Food Sci Nutr; 2022; 62(28):7929-7959. PubMed ID: 33955288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Potential of
    De Oliveira FL; Salgaço MK; de Oliveira MT; Mesa V; Sartoratto A; Peregrino AM; Ramos WS; Sivieri K
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional roles of short chain fatty acids as postbiotics in human gut: future perspectives.
    Ragavan ML; Hemalatha S
    Food Sci Biotechnol; 2024 Jan; 33(2):275-285. PubMed ID: 38222911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychobiotics: The Next-Generation Probiotics for the Brain.
    Sharma R; Gupta D; Mehrotra R; Mago P
    Curr Microbiol; 2021 Feb; 78(2):449-463. PubMed ID: 33394083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.
    O'Riordan KJ; Collins MK; Moloney GM; Knox EG; Aburto MR; Fülling C; Morley SJ; Clarke G; Schellekens H; Cryan JF
    Mol Cell Endocrinol; 2022 Apr; 546():111572. PubMed ID: 35066114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychobiotics: a novel class of psychotropic.
    Dinan TG; Stanton C; Cryan JF
    Biol Psychiatry; 2013 Nov; 74(10):720-6. PubMed ID: 23759244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From isoniazid to psychobiotics: the gut microbiome as a new antidepressant target.
    Butler MI; Sandhu K; Cryan JF; Dinan TG
    Br J Hosp Med (Lond); 2019 Mar; 80(3):139-145. PubMed ID: 30860919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix Effects on the Delivery Efficacy of Bifidobacterium animalis subsp.
    Ba Z; Lee Y; Meng H; Kris-Etherton PM; Rogers CJ; Lewis ZT; Mills DA; Furumoto EJ; Rolon ML; Fleming JA; Roberts RF
    mSphere; 2021 Aug; 6(4):e0008421. PubMed ID: 34232082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota.
    Fusco W; Lorenzo MB; Cintoni M; Porcari S; Rinninella E; Kaitsas F; Lener E; Mele MC; Gasbarrini A; Collado MC; Cammarota G; Ianiro G
    Nutrients; 2023 May; 15(9):. PubMed ID: 37432351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of short-chain fatty acids in microbiota-gut-brain communication.
    Dalile B; Van Oudenhove L; Vervliet B; Verbeke K
    Nat Rev Gastroenterol Hepatol; 2019 Aug; 16(8):461-478. PubMed ID: 31123355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotics and fructo-oligosaccharide intervention modulate the microbiota-gut brain axis to improve autism spectrum reducing also the hyper-serotonergic state and the dopamine metabolism disorder.
    Wang Y; Li N; Yang JJ; Zhao DM; Chen B; Zhang GQ; Chen S; Cao RF; Yu H; Zhao CY; Zhao L; Ge YS; Liu Y; Zhang LH; Hu W; Zhang L; Gai ZT
    Pharmacol Res; 2020 Jul; 157():104784. PubMed ID: 32305492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychobiotics in diet: significance and applications of neuroactive and psychoactive microbial metabolites.
    Giri R; Sharma RK
    Nutr Rev; 2022 Aug; 80(9):2002-2016. PubMed ID: 35352107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From probiotics to psychobiotics - the gut-brain axis in psychiatric disorders.
    Zagórska A; Marcinkowska M; Jamrozik M; Wiśniowska B; Paśko P
    Benef Microbes; 2020 Dec; 11(8):717-732. PubMed ID: 33191776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
    Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
    J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Psychobiotics in the Treatment of Psychiatric and Cognitive Disorders: A Systematic Review of Randomized Clinical Trials.
    Mosquera FEC; Lizcano Martinez S; Liscano Y
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remodeling of microbiota gut-brain axis using psychobiotics in depression.
    Palepu MSK; Dandekar MP
    Eur J Pharmacol; 2022 Sep; 931():175171. PubMed ID: 35926568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders.
    Cheng LH; Liu YW; Wu CC; Wang S; Tsai YC
    J Food Drug Anal; 2019 Jul; 27(3):632-648. PubMed ID: 31324280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: A systematic review.
    Barrio C; Arias-Sánchez S; Martín-Monzón I
    Psychoneuroendocrinology; 2022 Mar; 137():105640. PubMed ID: 34942539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of probiotic intervention in regulating gut microbiota, short-chain fatty acids and depression-like behavior in lead-exposed rats.
    Chen X; Meng S; Yu Y; Li S; Wu L; Zhang Y
    Int J Occup Med Environ Health; 2022 Feb; 35(1):95-106. PubMed ID: 35143471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Power of Psychobiotics in Depression: A Modern Approach through the Microbiota-Gut-Brain Axis: A Literature Review.
    Dziedzic A; Maciak K; Bliźniewska-Kowalska K; Gałecka M; Kobierecka W; Saluk J
    Nutrients; 2024 Apr; 16(7):. PubMed ID: 38613087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.